CUTHIVAC 001
Trial Details
- Trial statusCompleted
- Chief InvestigatorSheena McCormack
- Project managerAleisha Miller
- SponsorImperial College London
- ISRCTN numberNA
- Phase1
- View clinicaltrials.gov website
A Phase I clinical trial to assess the safety and immunogenicity of three HIV GTU® MultiHIV DNA immunisations administered via the Intramuscular, Intradermal and Transcutaneous routes
Design and Objective
Key inclusion criteria
1. Men and women aged between 18 and 45 years on the day of screening 2. BMI between 19-30 3. Available for follow-up for the duration of the study (~6 months from screening) 4. Written informed consent 5. At low risk of HIV 6. Willing to undergo a HIV test and a genital infection screen 7. Effective contraception 8. Registered with a GP